Heterozygous deletion of cyclin C gene (CCNC) has been linked to the progression of acute lymphoblastic leukemia [195], osteosarcoma [196], and thyroid [197] cancer, suggesting that cyclin C is a bona fide tumor suppressor. The gene discussed is CCNC; the disease is neoplasm.